Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples